Abingdon Health’s core technology is based on rapid lateral flow immunoassay diagnostics and associated reader systems.
We are also developing the next generation of multiplexed rapid diagnostics technology to meet the market need for simple-to-use, rapid, cost effective, portable system.
Download our eBook to see how we can help with lateral flow assay quantification https://t.co/PTGf44apwz https://t.co/sc7wNNAjdk
18 October 2017
© Abingdon Health 2017